Diverticular Disease

Symposium - Willem Bemelman (Netherlands) at Tripartite Colorectal Meeting 2014

Educational session - Sebastiano Biondo (Spain) at ESCP Nice 2018

Educational session - Sebastiano Biondo (Spain) at ESCP Nice 2018

Educational session - Goran Barisic (Serbia) at ESCP Berlin 2017

Oral Poster (IBD) - Thomas Golda at ESCP Barcelona 2014

Educational session - Johannes Schultz (Norway) at ESCP Vienna 2019

Top abstract 4 - Laura Mora-López (Spain) at ESCP Virtually Vilnius 2020

Global symposium - Surendra Mantoo (Singapore) at ESCP Dublin 2022

Global Symposium - Luqman Mazlan (Malaysia) at ESCP Vilnius 2023

Symposium - Nikolas Gouvas at ESCP Milan 2016

Symposium - Tom Øresland at ESCP Milan 2016

Symposium - Patricia Roberts at ESCP Milan 2016

Free Paper (Miscellaneous) - Nir Horesh at ESCP Dublin 2015

Guideline-based discussion - Eva Angenete (Sweden) at ESCP Barcelona 2021

Cohorts and Audits Symposium - Johanna Sigurdardottir (Sweden) at ESCP Dublin 2022

Symposium - Pascal Gervaz at ESCP Belgrade 2013

Symposium - Gian Andrea Binda at ESCP Belgrade 2013

Symposium - Tom Oresland at ESCP Belgrade 2013

Cohorts and Audits Symposium - Dale Vimalachandran (UK) at ESCP Dublin 2022

Free paper - Hugh Paterson at ESCP Vienna 2012

Colonic diverticulosis is among the most common diseases in developed Western countries, and its incidence is increasing as the average age of the population increases. Its etiology remains largely unknown. It is assumed that intestinal innervation disorders and structural alterations of the musculature induce abnormal contractile patterns with increased intraluminal pressure, thereby promoting the development of diverticula. The location of diverticula within the colon varies significantly among different regions of the world. In Western countries, primarily left-sided diverticulosis, particularly involving the sigmoid colon, has been well-described. This is in contrast to findings in Asia, where right-sided diverticulosis dominates. The actual prevalence of diverticulosis is difficult to determine because most individuals are asymptomatic. Acquired diverticular disease of the colon has been estimated to occur in 30 % of the population over the age of 45 years; 10–25 % of these individuals develop symptomatic diverticulitis. The clinical spectrum of diverticular disease varies from asymptomatic diverticulosis to symptomatic disease with potentially fatal complications, such as perforation or bleeding. Acute diverticulitis is treated according to severity. Computed tomography permits the complete evaluation of the location and extent of the inflammatory process, allowing appropriate, adapted clinical management. Treatment recommendations depend on the disease stage and include conservative approaches with observation and dietary modifications, as well as antibiotic treatment, abscess drainage, and surgery. A prerequisite for therapeutic decision making is an exact, comprehensive, and applicable classification of the disease before treatment. Several systems for classifying diverticular disease have been presented, but none of them has yet been universally adopted.

New Trials Forum - Dale Vimalachandran (UK) at ESCP Nice 2018

Global Symposium - Dale Vimalachandran (United Kingdom) at ESCP Vilnius 2023

Oral Poster (Miscellaneous and Neoplasia) - Maximilian Sohn at ESCP Dublin 2015

Free Paper (IBD) - Faes Seraina at ESCP Dublin 2015

Free Paper (Miscellaneous) - Sandra Vennix at ESCP Dublin 2015

One of the Six Best Papers - Fredrik Hjern at ESCP Vienna 2012

Educational session - Eva Angenete (Sweden) at ESCP Virtually Vilnius 2020

Education session - Ailsa Hart (United Kingdom) at ESCP Vilnius 2023

Educational session - Marja A Boermeester (The Netherlands) at ESCP Berlin 2017